Clinical Trials Logo

Lung Diseases, Obstructive clinical trials

View clinical trials related to Lung Diseases, Obstructive.

Filter by:

NCT ID: NCT01930526 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Single Leg Cycling in COPD: Knowledge Translation to Pulmonary Rehabilitation

Start date: July 2011
Phase: N/A
Study type: Interventional

Pulmonary rehabilitation (PR) with supervised exercise training is a key part of care for patients with chronic lung disease (COPD). Patients can improve their shortness of breath, walking distance and quality of life. However, many patients do not improve their overall fitness. They are too breathless to train at a high enough intensity. In a laboratory training study, patients with COPD improved their overall fitness by using single leg cycling. Despite this knowledge, single leg cycling has not been used clinically. The objective of this project is to use and assess single leg cycling in a clinical setting. Single leg cycling can be incorporated into a clinical service (replacing traditional two legged cycling) as the predominant aerobic training strategy, resulting in improvements in cardio-respiratory fitness (peak oxygen uptake).

NCT ID: NCT01922271 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

FAST
Start date: August 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to further figure out differences of glycopyrronium bromide compared to tiotropium in early bronchodilation measured by a comprehensive assessment of lung function that includes hyperinflation and specific airway resistance in patients with moderate to severe COPD.

NCT ID: NCT01922180 Completed - COPD Exacerbation Clinical Trials

Chronic Obstructive Pulmonary Disease: CT Features of Severe Exacerbation

Start date: July 2007
Phase: N/A
Study type: Observational

To describe Computed Tomography (CT) features associated with severe exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

NCT ID: NCT01921712 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Start date: July 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of PUR0200. In addition, the study will look at the blood levels of different doses of PUR0200 and their affect on lung function in COPD patients.

NCT ID: NCT01917331 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

Start date: March 2014
Phase: Phase 3
Study type: Interventional

Randomized,double-blind,multicenter,multinational,parallel-group,Phase III study to demonstrate the superiority of the triple fixed combination of Beclometasone+Formoterol+Glycopyrrolate (BDP/FF/GB) administered via pMDI over the equivalent dose of Foster® in COPD (Chronic Obstructive Pulmonary Disease) patients after 52 weeks of treatment

NCT ID: NCT01915784 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

Start date: July 2013
Phase: Phase 3
Study type: Interventional

Preference study: Genuair® (Pressair™) vs Breezhaler® (Neohaler™) inhalers in patients with COPD

NCT ID: NCT01911364 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

Start date: January 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the triple combination of beclometasone dipropionate+Formoterol fumarate+Glycopyrrolate bromide is effective for the treatment of severe COPD patients (chronic obstructive pulmonary disease)

NCT ID: NCT01908140 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: September 2013
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the efficacy, safety and tolerability of aclidinium bromide/formoterol fumarate and salmeterol/fluticasone propionate in patients with chronic obstructive pulmonary disease (COPD)

NCT ID: NCT01898143 Completed - Clinical trials for Interstitial Lung Disease (n=10)

Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease

Start date: June 2013
Phase: N/A
Study type: Interventional

Whole body vibration training seems to be a useful adjunct in exercise training in patients with severe COPD. The basic principle relies on reflectory muscle contractions caused by a vibration stimulus. Until now the impact of whole body vibration training on cardiopulmonary parameters remained unknown. Therefore aim of this study is to investigate cardiopulmonary parameters during whole body vibration training in patients with chronic lung disease.

NCT ID: NCT01897298 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Urban Training for COPD Patients

Start date: July 2013
Phase: N/A
Study type: Interventional

This project plans on a training intervention by using public spaces and urban walkable trails, adapted to each patient needs and capabilities. Primary objective is to assess 12 months effectiveness of the intervention with respect to: (primary outcome): physical activity level, and (secondary outcomes): COPD admissions, exercise capacity, body composition, quality of life, and mental health.